Volume 10,Issue 3
Application of Botulinum Toxin Type A after Plastic Surgery Incision and Its Impact on Patients' Complication Risks
Objective: To investigate the application effect of Botulinum Toxin Type A after plastic surgery incision and its impact on patients' complication risks. Methods: 104 patients who underwent plastic surgery incision in our hospital from February 2023 to June 2025 were selected and randomly divided into a control group (n=52) and an observation group (n=52) using a random number table method. Both groups underwent plastic surgery incision, while the observation group received additional application of Botulinum Toxin Type A. The treatment effects, skin conditions, complication rates, and patient satisfaction were compared between the two groups. Results: After intervention, the indicators of both groups improved compared to before treatment. The observation group showed significant advantages in various indicator improvements: In terms of treatment effect, the total clinical effective rate of the observation group (94.23%) was better than that of the control group (76.92%) (χ2=6.310, P=0.000<0.001); in terms of skin condition, the observation group showed more significant improvement (P=0.000<0.001 for all); in terms of adverse reaction rate, the observation group (1.92%) was lower than the control group (15.38%) (χ2=4.379, P=0.036<0.05); in terms of patient satisfaction, the total satisfaction rate of the observation group (96.15%) was better than that of the control group (80.77%) (χ2=6.029, P=0.014<0.01). Conclusion: The application of Botulinum Toxin Type A after plastic surgery incision can improve treatment effects, skin conditions, and patient satisfaction. Although the complication rate increases slightly, the overall safety is acceptable, making it worthy of clinical promotion.
[1] An X, Yang T, Huang J, 2025, Evaluation of the efficacy and safety of botulinum toxin in reducing postoperative tension after plastic surgery incision. China Medical Cosmetology, 15(03): 33-37.
[2] Liu B, Cui X, Qin A, 2020, Experimental study on the improvement of wound healing quality after cosmetic suture with closed negative pressure therapy. Shaanxi Medical Journal, 49(05): 553-556.
[3] Song L, Ye J, Lu M, 2020, Injection of botulinum toxin type A to prevent hypertrophic scars after facial trauma or surgery: a systematic review of efficacy and safety. Chinese Journal of Tissue Engineering Research, 24(29): 4744-4750.
[4] Li H, 2020, Current status of the application of botulinum toxin in cosmetic surgery. Military Surgeon in Southwest China, 22(02): 144-146.
[5] Yan X, Zhou J, Feng Y, 2025, Clinical application of modified external incision combined with botulinum toxin type A injection in nasal alar reduction plasty. Chinese Journal of Aesthetic and Plastic Surgery, 36(05): 283-284+319.
[6] Wang J, Dong Y, Cao Z, 2018, Observation on the curative effect of keloid surgery combined with botulinum toxin type A and superficial X-ray. Journal of Weifang Medical College, 40(05): 334-336+348.
[7] Che M, Zhang N, Yang R, 2021, Clinical study on the treatment of hypertrophic scars with botulinum toxin type A combined with triamcinolone acetonide. China Medical Cosmetology, 11(05): 13-16.
[8] Tao J, Liu B, Wang Y, 2018, Clinical study on the reduction of forehead postoperative scar hyperplasia with botulinum toxin type A. Shaanxi Medical Journal, 47(08): 1011-1013.
[9] Zhong Y, Liang F, 2020, Analysis of the cosmetic effect of botulinum toxin type A injection at fixed points of masseter muscle combined with hyaluronic acid injection for chin filling in reshaping female maxillofacial contour. Chinese and Foreign Women's Health Research, (13): 112-113.
[10] Liu K, 2018, Analysis of the effect of botulinum toxin type A masseter injection combined with hyaluronic acid chin injection for filling micro-plastic surgery in reshaping the lower 1/3 contour of the face. Guide of China Medicine, 16(10): 70-71.